search
Back to results

Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS) (CLESS)

Primary Purpose

Endometrioma

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
ethanol sclerotherapy
stripping technique
Sponsored by
Catholic University of the Sacred Heart
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Endometrioma focused on measuring endometrioma, ethanol, sclerotherapy, aspiration, ovarian reserve, endometriosis, AMH

Eligibility Criteria

18 Years - 35 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Women between 18-35 years old
  • Women with ultrasound diagnosis of ovarian endometrioma ≥4cm (with or without deep infiltrating endometriosis)
  • History of dysmenorrhea and/or chronic pelvic pain
  • candidates for elective laparoscopy due to endometriosis.

Exclusion Criteria:

  • - Previous surgery for ovarian endometriosis
  • Evidence of premature ovarian failure (follicle stimulating hormone ≥40 international units/L)
  • Endocrinal disorders that might affect ovarian function (e.g., polycystic ovary syndrome, thyroid dysfunction, hyperprolactinemia)
  • Ultrasound suspicious of ovarian malignant disease according IOTA criteria
  • endometrial cyst < 4 cm. • ethanol sensitivity.

Sites / Locations

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCSRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Aspiration and Sclerotherapy of endometriomas

laparoscopic stripping technique

Arm Description

Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas

cystectomy of endometriomas during laparoscopy

Outcomes

Primary Outcome Measures

impact on ovarian reserve, in terms of reduction of serum AMH levels
The AMH levels will be evaluated 1 month before the surgery and 1, 6 and 12 months after surgery.

Secondary Outcome Measures

endometrioma recurrence rate for the two surgical techniques
Ultrasound examination that demonstrate the presence/lack of ovarian cyst with sonographic features of endometrioma in the ovary where the procedure took place.
pain relief after surgery
The severity of pelvic pain , assessed using a visual analogue scale with no-pain classified as 0 and worst imaginable pain as 10.

Full Information

First Posted
November 25, 2019
Last Updated
December 2, 2019
Sponsor
Catholic University of the Sacred Heart
search

1. Study Identification

Unique Protocol Identification Number
NCT04178876
Brief Title
Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS)
Acronym
CLESS
Official Title
Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy: Impact on Ovarian Reserve.
Study Type
Interventional

2. Study Status

Record Verification Date
December 2019
Overall Recruitment Status
Unknown status
Study Start Date
September 13, 2019 (Actual)
Primary Completion Date
November 1, 2022 (Anticipated)
Study Completion Date
June 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Catholic University of the Sacred Heart

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The aim of this study is to compare two different laparoscopic surgical techniques (endometrioma stripping vs ethanol sclerotherapy) in terms of ovarian reserve (AMH levels), recurrence rate and pain relief.
Detailed Description
Patients with pelvic pain (VAS score≥4) and ultrasound diagnosis of endometrioma > 4cm candidate to surgical removal of endometrioma will be randomized into 2 group. One Group will undergo laparoscopical stripping technique; the other one will undergo laparoscopic aspiration and sclerotherapy using 95% ethanol. The women will be introduced with both operative options and they will be informed about the randomization . After an elaborate explanation about the study they will sign an informed consent form. the following data will be collected prior the operation: age, gravity & parity, operative history, general medical history, the cyst size, AMH (Anti Mullerian Hormone), symptoms related to endometriosis (through VAS score), fertility history including any fertility treatment in the past and planned pregnancy after the operation. The laparoscopy will take place in Fondazione Policlinico Gemelli IRCSS, Roma. in the study group the cyst content will be aspirated and flushed with normal saline. 95% sterile ethanol will be instilled into the cyst through a Nelathon catheter. Ethanol will be left in the cyst for 15 min then aspirated as completely as possible following normal saline flushing. In the control group we will follow the standard treatment which is cystectomy. The women will be followed at 1 , 3 , 6 and 12 months after the surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endometrioma
Keywords
endometrioma, ethanol, sclerotherapy, aspiration, ovarian reserve, endometriosis, AMH

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
64 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Aspiration and Sclerotherapy of endometriomas
Arm Type
Experimental
Arm Description
Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas
Arm Title
laparoscopic stripping technique
Arm Type
Active Comparator
Arm Description
cystectomy of endometriomas during laparoscopy
Intervention Type
Procedure
Intervention Name(s)
ethanol sclerotherapy
Intervention Description
Endometrioma laparoscopic aspiration and sclerotherapy using 95% ethanol
Intervention Type
Procedure
Intervention Name(s)
stripping technique
Intervention Description
Endometrioma laparoscopic cystectomy
Primary Outcome Measure Information:
Title
impact on ovarian reserve, in terms of reduction of serum AMH levels
Description
The AMH levels will be evaluated 1 month before the surgery and 1, 6 and 12 months after surgery.
Time Frame
up to 12 months after the laparoscopy
Secondary Outcome Measure Information:
Title
endometrioma recurrence rate for the two surgical techniques
Description
Ultrasound examination that demonstrate the presence/lack of ovarian cyst with sonographic features of endometrioma in the ovary where the procedure took place.
Time Frame
up to 12 months after the laparoscopy
Title
pain relief after surgery
Description
The severity of pelvic pain , assessed using a visual analogue scale with no-pain classified as 0 and worst imaginable pain as 10.
Time Frame
up to 12 months after the laparoscopy

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
This is a Gynecological study
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women between 18-35 years old Women with ultrasound diagnosis of ovarian endometrioma ≥4cm (with or without deep infiltrating endometriosis) History of dysmenorrhea and/or chronic pelvic pain candidates for elective laparoscopy due to endometriosis. Exclusion Criteria: - Previous surgery for ovarian endometriosis Evidence of premature ovarian failure (follicle stimulating hormone ≥40 international units/L) Endocrinal disorders that might affect ovarian function (e.g., polycystic ovary syndrome, thyroid dysfunction, hyperprolactinemia) Ultrasound suspicious of ovarian malignant disease according IOTA criteria endometrial cyst < 4 cm. • ethanol sensitivity.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alessandra De Cicco Nardone, MD
Phone
+393428235829
Email
alessandradecicco@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Giovanni Scambia, MD
Organizational Affiliation
Fondazione Policlinico Gemelli, IRCSS Università Cattolica del Sacro Cuore, Roma
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
City
Roma
ZIP/Postal Code
00168
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alessandra De Cicco Nardone, MD
Email
alessandradecicco@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
IPD Sharing Time Frame
data will become available following publication.
IPD Sharing Access Criteria
To gain access, data requestors will need to sign a data access agreement.
Citations:
PubMed Identifier
30193971
Citation
Sweed MS, Makled AK, El-Sayed MA, Shawky ME, Abd-Elhady HA, Mansour AM, Mohamed RM, Hemeda H, Nasr-Eldin EA, Attia NS, Eltaieb E, Allam H, Hussein A. Ovarian Reserve Following Laparoscopic Ovarian Cystectomy vs Cyst Deroofing for Endometriomas. J Minim Invasive Gynecol. 2019 Jul-Aug;26(5):877-882. doi: 10.1016/j.jmig.2018.06.022. Epub 2018 Sep 5.
Results Reference
background
PubMed Identifier
28579409
Citation
Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017 Jul;108(1):117-124.e5. doi: 10.1016/j.fertnstert.2017.05.015. Epub 2017 Jun 1.
Results Reference
background
PubMed Identifier
14581861
Citation
Messalli EM, Cobellis G, Pecori E, Pierno G, Scaffa C, Stradella L, Cobellis L. Alcohol sclerosis of endometriomas after ultrasound-guided aspiration. Minerva Ginecol. 2003 Aug;55(4):359-62.
Results Reference
background
PubMed Identifier
25739052
Citation
Garcia-Tejedor A, Castellarnau M, Ponce J, Fernandez ME, Burdio F. Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimal invasive procedure. Preliminary results. Eur J Obstet Gynecol Reprod Biol. 2015 Apr;187:25-9. doi: 10.1016/j.ejogrb.2015.02.004. Epub 2015 Feb 16.
Results Reference
background
PubMed Identifier
30396562
Citation
Kovacevic VM, Andelic LM, Mitrovic Jovanovic A. Changes in serum antimullerian hormone levels in patients 6 and 12 months after endometrioma stripping surgery. Fertil Steril. 2018 Nov;110(6):1173-1180. doi: 10.1016/j.fertnstert.2018.07.019.
Results Reference
background

Learn more about this trial

Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS)

We'll reach out to this number within 24 hrs